Brief: Ayala Pharmaceuticals Completes Sale Of AL102 To Immunome
26/03/2024 12:08
March 26 (Reuters) - Ayala Pharmaceuticals Inc
ADXS.PK :
* AYALA PHARMACEUTICALS ANNOUNCES COMPLETION OF SALE OF
AL102 TO
IMMUNOME
Source text for Eikon: ID:nGNX3WWPrz
Further company coverage: ADXS.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Immunome
See all newsBrief: Immunome - Enters Amendment No. 4 To License Agreement With Bristol-Myers Squibb Company On Oct 2, 2026
US STOCKS ON THE MOVE-Cardinal Health, nVent, Acuity
U.S. STOCKS ON THE MOVE-Cardinal Health, Fervo Energy, Rocket Lab
U.S. STOCKS ON THE MOVE-Progress Software, Vicor Corp, Accenture
Immunome climbs as Stifel initiates coverage